Efficacy of N-acetylcysteine <i>vs</i> dexamethasone in preventing postembolization syndrome post-transarterial chemoembolization in hepatocellular carcinoma: A randomized controlled trial
Compared with DEXA, NAC significantly reduces the incidence of PES, regardless of its impact on liver function recovery. Therefore, NAC is a preferable option for reducing PES in Barcelona Clinic Liver Cancer-B stage HCC patients with preserved liver function.
Authors
- Torpong Claimon (ORCID: https://orcid.org/0000-0002-6613-2650)
- Nitipon Simasingha (ORCID: https://orcid.org/0000-0002-7883-3294)
- Wasu Tanasoontrarat (ORCID: https://orcid.org/0000-0003-1698-4465)
- Supatsri Sethasine (ORCID: https://orcid.org/0000-0002-7637-3669)
- Witchakorn Ruamtawee
- Preeyamas Koonsiripaiboon
Institutions
- Navamindradhiraj University (TH)
- Udon Thani Hospital (TH)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2025-08-18
- DOI
- https://doi.org/10.3748/wjg.v31.i31.109630
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32